Publications by authors named "Adam Glassman"

Claim this Profile
B
Benefits and Limitations of Using Population Databases for Eye Research-More Than Meets the Eye.
Dolly Ann Padovani-Claudio, Adam R Glassman

JAMA Ophthalmol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-Vascular Endothelial Growth Factor Options and Questions for Diabetic Eye Disease Treatment.
Adam R Glassman

JAMA Ophthalmol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Factors for Meeting Criteria for Switching from Bevacizumab to Aflibercept When Treating Eyes with Diabetic Macular Edema and Visual Acuity of < 20/40.
Chirag D Jhaveri, Danni Liu, Maureen G Maguire, Adam R Glassman, Ruben A Grigorian

Ophthalmology· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Home OCT Imaging for Newly Diagnosed Neovascular Age-Related Macular Degeneration: A Feasibility Study.
Kevin J Blinder, Claire Calhoun, Maureen G Maguire, Adam R Glassman, Calvin E Mein

Ophthalmol Retina· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visual Function Measurements in Eyes With Diabetic Retinopathy: An Expert Opinion on Available Measures.
Adam R Glassman, Mohamed Ashraf Elmasry, Darrell E Baskin, Mitchell Brigell, Victor Chong

Ophthalmol Sci· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Report From the 2022 Mary Tyler Moore Vision Initiative Diabetic Retinal Disease Clinical Endpoints Workshop.
S Robert Levine, Martin G Myers, Ryan Barunas, Dolly S Chang, Sanjoy Dutta, Adam Glassman

Transl Vis Sci Technol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Four-Year Visual Outcomes After Intravitreous Aflibercept for Vision-Threatening Complications of Diabetic Retinopathy-Reply.
Jennifer K Sun, Adam R Glassman, Raj K Maturi,

JAMA· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of Aflibercept Monotherapy vs Bevacizumab First Followed by Aflibercept If Needed for Diabetic Macular Edema.
David W Hutton, Adam R Glassman, Danni Liu, Jennifer K Sun,

JAMA Ophthalmol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.
Raj K Maturi, Adam R Glassman, Kristin Josic, Carl W Baker, Adam T Gerstenblith

JAMA· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Predominantly Peripheral Lesions on Ultra-Widefield Imaging and the Risk of Diabetic Retinopathy Worsening Over Time.
Dennis M Marcus, Paolo S Silva, Danni Liu, Lloyd Paul Aiello, Andrew Antoszyk, Adam R Glassman

JAMA Ophthalmol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Ultra-Widefield Fluorescein Angiography-Identified Retinal Nonperfusion and the Risk of Diabetic Retinopathy Worsening Over Time.
Paolo S Silva, Dennis M Marcus, Danni Liu, Lloyd Paul Aiello, Andrew Antoszyk, Adam R Glassman

JAMA Ophthalmol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Reported Outcome Measures in a Clinical Trial of the Port Delivery System With Ranibizumab.
Wesley T Beaulieu, Adam R Glassman

JAMA Ophthalmol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema.
Chirag D Jhaveri, Adam R Glassman, Frederick L Ferris, Danni Liu, Maureen G Maguire

N Engl J Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASSESSMENT OF FLUORESCEIN ANGIOGRAPHY NONPERFUSION IN EYES WITH DIABETIC RETINOPATHY USING ULTRAWIDE FIELD RETINAL IMAGING.
Paolo S Silva, Danni Liu, Adam R Glassman, Lloyd P Aiello, Sandeep Grover

Retina· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized Trial of Photobiomodulation Therapy for Center-Involved Diabetic Macular Edema with Good Visual Acuity (Protocol AE).
Judy E Kim, Adam R Glassman, Kristin Josic, Michele Melia, Lloyd P Aiello

Ophthalmol Retina· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spotlight on the DRCR Retina Network's Photobiomodulation for Diabetic Macular Edema Trial.
Jennifer K Sun, Adam R Glassman, Lee M Jampol

JAMA Ophthalmol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing Center-Involved Diabetic Macular Edema With Good Visual Acuity.
Jennifer K Sun, Adam R Glassman, Lee M Jampol

JAMA Ophthalmol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lapses in Care Among Patients Assigned to Ranibizumab for Proliferative Diabetic Retinopathy: A Post Hoc Analysis of a Randomized Clinical Trial.
Maureen G Maguire, Danni Liu, Susan B Bressler, Scott M Friedman, Michele Melia, Adam R Glassman

JAMA Ophthalmol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conversion of Central Subfield Thickness Measurements of Diabetic Macular Edema Across Cirrus and Spectralis Optical Coherence Tomography Instruments.
Jennifer K Sun, Kristin Josic, Michele Melia, Adam R Glassman, Clare Bailey

Transl Vis Sci Technol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pneumatic Vitreolysis with Perfluoropropane for Vitreomacular Traction with and without Macular Hole: DRCR Retina Network Protocols AG and AH.
Clement K Chan, Calvin E Mein, Adam R Glassman, Wesley T Beaulieu, Claire T Calhoun

Ophthalmology· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Costs of Managing Diabetic Macular Edema With Good Visual Acuity With Aflibercept, Laser, or Observation: DRCR Retina Network Protocol V.
David W Hutton, Adam R Glassman, Joshua D Stein, Neil M Bressler, Jennifer K Sun

Am J Ophthalmol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Intravitreous Anti-Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial.
Raj K Maturi, Adam R Glassman, Kristin Josic, Andrew N Antoszyk, Barbara A Blodi

JAMA Ophthalmol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visual Acuity, Vitreous Hemorrhage, and Other Ocular Outcomes After Vitrectomy vs Aflibercept for Vitreous Hemorrhage Due to Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial.
Adam R Glassman, Wesley T Beaulieu, Maureen G Maguire, Andrew N Antoszyk, Clement C Chow

JAMA Ophthalmol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optical Coherence Tomography Angiography Quality Across Three Multicenter Clinical Studies of Diabetic Retinopathy.
Brandon J Lujan, Claire T Calhoun, Adam R Glassman, Joseph M Googe, Lee M Jampol

Transl Vis Sci Technol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Initial Aflibercept, Laser, or Observation on Low-Contrast Visual Acuity in Eyes With Diabetic Macular Edema and Good Vision: Ancillary Study Within a Randomized Clinical Trial.
Wesley T Beaulieu, Adam R Glassman, Carl W Baker, Maureen G Maguire, Chris A Johnson

Transl Vis Sci Technol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis